HOP S. TRAN CAO to Carcinoma, Hepatocellular
This is a "connection" page, showing publications HOP S. TRAN CAO has written about Carcinoma, Hepatocellular.
Connection Strength
1.310
-
Treatment Disparities Partially Mediate Socioeconomic- and Race/Ethnicity-Based Survival Disparities in Stage I-II Hepatocellular Carcinoma. Ann Surg Oncol. 2023 Nov; 30(12):7309-7318.
Score: 0.387
-
Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). 2023 Jul; 25(7):758-765.
Score: 0.374
-
Benign hepatic incidentalomas. Curr Probl Surg. 2019 09; 56(9):100642.
Score: 0.287
-
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma. Oncology. 2023; 101(11):730-737.
Score: 0.096
-
Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol. 2021 Mar; 36:138-146.
Score: 0.080
-
Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
Score: 0.069
-
Hospital Minimally Invasive Surgery Utilization for Gastrointestinal Cancer. Ann Surg. 2018 08; 268(2):303-310.
Score: 0.017